Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up
Paediatrics
Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up
Paediatrics

Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up

Diabetes Care. 2025 Oct 9:dc251743. doi: 10.2337/dc25-1743. Online ahead of print.

NO ABSTRACT

PMID:41066718 | DOI:10.2337/dc25-1743